Synpromics Ltd company
Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations. The company was founded in 2010 and is based in Edinburgh, United Kingdom.
Estimated Revenue:
$1M to $10M
Funding Status:
N/A
Industry:
Personalized Medicine
Investors Number:
3
Number Of Exists:
Grant
Technology:
Regenerative Medicine
Founded Date:
2010
Investor Type:
Company
Headquarters:
Edinburgh, Edinburgh, City of, United Kingdom
Total Funding:
£9.2M
Last Funding Type:
Grant
Employee Number:
1-10
Investment Stage:
N/A